FAFGX | SCGSX | FAFGX / SCGSX | |
Total Expense Ratio | 0.40 | 0.66 | 61% |
Annual Report Gross Expense Ratio | 0.40 | 0.66 | 61% |
Fund Existence | 5 years | 25 years | - |
Gain YTD | 11.291 | 8.135 | 139% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 323B | 2.31B | 13,995% |
Annual Yield % from dividends | 0.53 | 0.00 | - |
Returns for 1 year | 11.14 | 5.71 | 195% |
Returns for 3 years | 61.52 | 45.86 | 134% |
Returns for 5 years | N/A | 37.06 | - |
Returns for 10 years | N/A | 74.60 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
STSCX | 40.63 | 0.29 | +0.72% |
Sterling Capital SmCp Val Instl | |||
CADPX | 21.74 | 0.13 | +0.60% |
Columbia International Div Inc Inst2 | |||
IBARX | 25.07 | 0.13 | +0.52% |
Macquarie Balanced Fund Class R6 | |||
CIEQX | 12.72 | 0.02 | +0.16% |
Segall Bryant & Hamll Intl Eq Inst | |||
SHSCX | 49.38 | 0.08 | +0.16% |
BlackRock Health Sciences Opps Inv C |